EZH2 can physically interact with signal transducer and activator of transcription 3 (STAT3) and methylate STAT3 directly, promoting nuclear retention and increasing the activity of STAT3 and therefore exacerbating cancer.8 This evidence concerns the gene EZH2 and cancer.